, Tracking Stock Market Picks
Enter Symbol:
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Neutral SNN
up 11.70 %

Smith & Nephew Snats, Inc. (SNN) downgraded to Neutral by Citigroup

Posted on: Tuesday,  Aug 13, 2013  8:25 AM ET by Citigroup

Citigroup rated Neutral Smith & Nephew Snats, Inc. (NYSE: SNN) on 08/13/2013. Previously Citigroup rated Buy Smith & Nephew Snats, Inc. (NYSE: SNN)
on 09/10/2012., when the stock price was $21.73. Since then, Smith & Nephew Snats, Inc. has gained 11.71% as of 08/13/2013's recent price of $24.27.
If you would have followed the previous Citigroup's recommendation on SNN, you would have gained 11.7% of your investment in 337 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2013 8:25 AM Hold
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD up  9.53 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2012 8:25 AM Buy
2/18/2009 8:25 AM Buy
5/8/2008 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy